- Wellgistics to integrate XRP Ledger for real-time, low-cost healthcare payments.
- $50M credit line from LDA Capital will fund XRP acquisitions and platform development.
- SEC filing highlights regulatory risks but confirms XRP as core treasury asset.
Wellgistics Health, Inc. has filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC), outlining a multi-phase strategy to adopt XRP for treasury and transactional purposes. The move follows a $50 million equity credit line agreement announced in May with LDA Capital, which will provide funding flexibility as the company shifts toward blockchain-enabled infrastructure.
According to the filing, Wellgistics plans to deploy the XRP Ledger (XRPL) across its payment and financing operations, positioning the digital asset as a core part of its business model. The Florida-based firm, which is listed on Nasdaq under the ticker WGRX, intends to use XRP both for direct payments and as collateral for financing.
XRP Integration Targets Transactional Efficiency
The company stated that it will implement XRP in its payment systems to facilitate near-instant, low-cost transactions involving pharmacies, drug manufacturers, and vendors. Its logistics network currently includes approximately 6,000 pharmacies and 150 manufacturing partners. Wellgistics aims to streamline payment flows using XRPL, a blockchain-based platform developed for fast and secure asset transfers.
The filing clarified that XRP will not be used passively but will instead function as a tool for real-time settlements and financial infrastructure upgrades. These capabilities are intended to reduce payment delays and operational friction, especially across business-to-business transactions. The firm’s leadership highlighted the possibility of blockchain technology to modernize legacy healthcare payment systems.
Capital Strategy to Acquire and Use XRP as Collateral
To support its adoption plans, Wellgistics outlined a strategy to raise funds through equity and debt offerings, with the capital earmarked for XRP accumulation. The company plans to increase its digital asset holdings gradually, with XRP intended to serve as both a treasury reserve and collateral for future financing activities.
The SEC filing shows that XRP holdings may be pledged to support liquidity access without disrupting operational budgets. The company noted that this financial arrangement is expected to reduce dependency on traditional short-term lending and diversify funding sources. Wellgistics also pointed to income-generating strategies tied to XRP as a method for enhancing balance sheet efficiency.
The company’s XRP initiative follows a $50 million equity line of credit signed with LDA Capital. Under the agreement, Wellgistics is authorized to issue shares over time in exchange for capital to be deployed into infrastructure development and asset acquisition. A portion of the funding will be allocated toward building out the firm’s XRPL-based payment platform.
The firm said this infrastructure will span its nationwide partner network and support broader digital finance adoption in the healthcare sector. The SEC submission links the credit facility directly to Wellgistics’ plans to expand its blockchain capabilities.
Regulatory Disclosure Acknowledges Legal Risks
In its S-1, Wellgistics acknowledged that its adoption of XRP comes with legal and regulatory uncertainties. The document noted ongoing litigation and evolving regulatory interpretations that could affect the value and classification of XRP.
Despite potential legal exposure, Wellgistics stated that it intends to proceed with the integration of XRPL into its financial systems. The filing also addressed broader skepticism around XRP’s utility, presenting its application plan as evidence of a defined use case in corporate finance.
